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Background
The partial capacity of HAART of reverting the immu-
nological dysfunction associated with HIV-1 infection
has stimulated the clinical investigation of cytokines as
molecules endowed with strong immunological reconsti-
tution potential.
Methods
Among other cytokines, cytokines utilizing a common g-
receptor chain for signal transduction (such as interleu-
kin-2, IL-2, and IL-7) have been particularly studies for
their high potential of boosting the adaptive immune
response and of stimulating the proliferation of mature
CD4+ and CD8+ T lymphocytes or of their precursors.
In addition, GM-CSF, sharing some signaling pathways
and clinical effects with IL-2 (i.e. boosting of CD4
+ T
cell counts), has also been studied. The recent failure of
phase III trials on the use of intermittent IL-2 adminis-
tration in spite of its proven effect of increasing CD4+
T cell counts poses the question of whether these
approach maintain interest and rationale to be pursued
in the context of successful HAART regimens.
Results
Clinical experimentations with IL-7 and GM-CSF are
still ongoing and maintain promising potential. We have
recently reported that intermittent IL-2 therapy counter-
acts the in vivo evolution of HIV-1 from CCR5 mono-
tropic use to dualtropic (CCR5 and CXCR4) use
(S. Ghezzi et al., HIV Medicine, 2009 Dec 8). IL-7 is also
considered a powerful tool to purge viral reservoir
embedded in resting memory CD4+ T cells. In this
regard, most HIV+ individuals show the constitutive
activation of a cleaved form of signal transducer and
activator of transcription-5 (STAT5), commonly
activated by IL-2, IL-7 and GM-CSF, therefore generat-
ing a transdominant negative inhibitor of STAT-5
dependent gene expression (A. Crotti et al., Blood,
2007).
Conclusions
Cytokines maintain their potential to complement
HAART at least in those patients discordantly respond-
ing to antiretroviral agents. Furthermore, certain cyto-
kines may be useful in the purge or attrition of viral
reservoirs in the perspective of eradicating HIV
infection.
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